{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:54:55Z","timestamp":1760784895873,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jneuroim.2020.577364","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:20:59Z","timestamp":1599132059000},"page":"577364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["AChR-and MuSK-positive myasthenia gravis: Double trouble"],"prefix":"10.1016","volume":"348","author":[{"given":"Vasiliki","family":"Zouvelou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erasmia","family":"Psimenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577364_bb0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1212\/01.wnl.0000228225.23349.5d","article-title":"Anti-MuSK antibodies: correlation with myasthenia gravis severity","volume":"67","author":"Bartoccioni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577364_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cen3.12319","article-title":"Role of the thymus in autoimmune myasthenia gravis","volume":"7","author":"Berrih-Akin","year":"2016","journal-title":"Clin. Exp. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1102\/1470-7330.2005.0107","article-title":"Imaging of thymic disorders","volume":"5","author":"Bogot","year":"2005","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.jneuroim.2020.577364_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-0036-1586265","article-title":"Myasthenia gravis","volume":"36","author":"Drachman","year":"2016","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/1744666X.2016.1110487","article-title":"Overcoming challenges in the diagnosis and treatment of myasthenia gravis","volume":"12","author":"Evoli","year":"2016","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0030","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00415-015-7982-2","article-title":"Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis","volume":"263","author":"Jordan","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0035","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00415-009-5215-2","article-title":"Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy","volume":"256","author":"Kostera-Pruszczyk","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2020.577364_bb0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clineuro.2018.06.041","article-title":"Clinical characteristics of AChR and MuSK Ab double seropositive myasthenia gravis patients","volume":"172","author":"Li","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Merigglioli","year":"2012","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2020.577364_bb0055","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","article-title":"Anti-MuSK antibody after thymectomy in a previously seropositive myasthenic child","volume":"69","author":"Saulat","year":"2007","journal-title":"Neurol"},{"issue":"5","key":"10.1016\/j.jneuroim.2020.577364_bb0060","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1002\/mus.26040","article-title":"Double seropositive myasthenia gravis: a 5-year-follow-up","volume":"57","author":"Zouvelou","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2020.577364_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2013.12.012","article-title":"AChR-myasthenia gravis switching to double seropositive several years after the onset","volume":"267","author":"Zouvelou","year":"2014","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820303052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572820303052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:37:47Z","timestamp":1759048667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572820303052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":13,"alternative-id":["S0165572820303052"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577364","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AChR-and MuSK-positive myasthenia gravis: Double trouble","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577364"}}